|
 |
| ORIGINAL ARTICLE |
|
| Year : 2013 | Volume
: 5
| Issue : 2 | Page : 69-72 |
|
|
Hormonal profile in Indian men with premature androgenetic alopecia
Smita Narad1, Sushil Pande2, Madhur Gupta1, Suresh Chari1
1 Department of Biochemistry, NKP Salve Institute of Medical Sciences and Research Center, Nagpur, Maharashtra, India
2 Department of Dermatology, NKP Salve Institute of Medical Sciences and Research Center, Nagpur, Maharashtra, India
| Date of Web Publication | 12-Dec-2013 |
Correspondence Address:
Smita Narad
401, Girish Heights, Nagpur Kamptee Road, Near LIC Square, Sadar, Nagpur - 440 001, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-7753.122961
 Abstract | | |
Introduction: Alopecia in male is considered as a genetically determined disorder characterized by increased level of local androgen metabolite and increase androgen receptor binding in balding areas. Frequent deviations of hormones from normal values have been reported in men diagnosed with premature androgenetic alopecia (AGA) especially for androgens, gonadotropins and sex hormone binding globulin (SHBG). Different studies in the past have inferred that premature baldness before the age of thirty in males could be considered equivalent to the polycystic ovary syndrome (PCOS) in female. Materials and Methods: Hormonal profile of 50 men with severe premature balding before 30 years of age were compared with same numbers of age matched controls. The serum concentrations of total testosterone, dehydroepiandrosterone sulfate, luteinizing hormone, follicle stimulating hormone, SHBG, insulin and fasting blood sugar were estimated. Statistical analysis was performed with paired Student's t-test for cases and controls. Results: Decreased levels of SHBG with high free androgen index were found in cases when compared with the controls. Conclusion: Though altered hormonal profile may coexist in some of men with premature AGA it can't be considered as male equivalent to PCOS in female or the metabolic syndrome. Keywords: Androgenetic alopecia, hormonal profile, polycystic ovary syndrome, premature androgenetic alopecia
How to cite this article:
Narad S, Pande S, Gupta M, Chari S. Hormonal profile in Indian men with premature androgenetic alopecia. Int J Trichol 2013;5:69-72 |
| Introduction | |  |
Androgenetic alopecia (AGA) is considered as a genetically determined disorder characterized by increased level of local androgen metabolite and increased androgen receptor binding in genetically predisposed men. [1] AGA developed before 30 years of age and reached at least stage 3 of Hamilton-Norwood classification is termed as premature AGA. [2] Premature AGA not only adds to psychological stress but also reported as the risk factor of carcinoma prostate [3] cardiovascular diseases [4] and metabolic syndromes. [5]
Estimation of serum hormones is essential for management of AGA and hirsutism in females. Abnormality of hair distribution like alopecia or marked hypertrichosity is commonly observed in the first line relatives of women suffering from the polycystic ovary syndrome (PCOS). [6],[7]
PCOS is a multifactorial disorder that leads to hormonal and metabolic imbalance with autosomal dominant trait of transmittance in female. [8],[9] PCOS is characterized by the coexistence of anovulation and hyperandrogenism in the form of hyperandrogenemia, high free androgen index (FAI), low follicle stimulating hormones (FSH), high luteinizing hormone (LH) and insulin resistance. [9] The previous studies have revealed the association of premature AGA in men with decreased levels of sex hormone binding globulin (SHBG), high FAI and insulin resistance. Disproportionate levels of serum gonadotrophins like low FSH, high LH have been demonstrated in some men with premature AGA. [7],[10],[11],[12]
Considering autosomal dominant nature of PCOS in females, it has been suggested that same can be expressed in males as a premature AGA. [12] With reference to similarity of hormonal profiles of men with premature AGA and PCOS in female, hypothesis of existence of a male PCOS equivalent in men with premature AGA was put forward and tested in various studies. [7],[10],[11],[12] Most of these studies have been conducted outside India, hence we intended to study the hormonal profile in Indian men with premature balding.
| Materials and Methods | | |
A case-control study approved by the Institutional Ethics Committee was carried out at NKP Salve Institute of Medical Sciences and Lata Mangeshkar Hospital, Nagpur from August 2010 to July 2012. A total of 50 males below the age of 30 years with premature balding (with alopecia defined as grade 3 vertex or more) attending Dermatology outpatient department (OPD) of our institute were included. Classification scale of Hamilton with Norwood was used for grading of AGA. [13] Equal number of age matched controls were selected from patients attending dermatology OPD. The patients and controls having endocrine or immune diseases, on steroid medication over the previous 3 months, obesity or having other causes of alopecia were excluded from the study.
Basal blood samples for determination of hormonal and biochemical parameters were taken between 7 a.m. and 8.30 a.m. after overnight fasting. A volume of 5 ml of venous blood was collected in the plain bulb and 1 ml of blood was collected in a fluoride bulb. Blood samples were centrifuged at 1509 g. Fasting blood sugar was estimated by Glucose Oxidase-Peroxidase method on fully automated analyzer Selectra E® . The serum was frozen at − 20°C for analysis. Serum total testosterone, dehydroepiandrosterone sulfate (DHEA-S), LH, FSH and Insulin were estimated on Lumax® analyzer by Chemiluminance technique using Acculyte® CLIA micorwells and Kit (Lilac medicare™ ). SHBG was estimated by ELISA method (Diasource® kit).
Statistical analysis was performed with Student's 't'- test and P < 0.05 was considered to be significant.
| Results | | |
The entire participants of the study were below 30 years of age. Cases were in the age group of 21-29 years with a mean age of 25 years while age group of control was from 21 to 28 years with the mean of 24 years. Average grade of AGA was grade III vertex in cases while all controls chosen had normal hair line. [13] Hormonal profile of all controls was within standard limits (according to literature of a kit) while hormonal profile of cases showed some deviation from the normal levels. Fasting blood glucose was normal in all cases and controls.
When compared with control there was no statistically significant difference found in serum total testosterone, DHEA-S, FSH, LH and Insulin levels. Half of the patients showed SHBG levels lower than its reference range and its levels were decreased significantly in cases when compared with the control. FAI = Total Testosterone/SHBG × 100 found to be significantly higher in cases than the controls (P = 0.0006). Fasting blood sugar and serum insulin levels were normal in cases as well as in controls. Fasting glucose insulin ratio (FGIR) i.e. ratio of fasting blood sugar to the insulin levels was calculated to estimate insulin resistance. There was no statistically significant difference found in FGIR of cases and controls [Table 1]. | Table 1: Comparisons of serum hormones levels between cases of premature AGA and controls
Click here to view |
| Discussion | | |
AGA is the most prevalent form of alopecia in men having polygenic origin. Total testosterone levels were within normal levels did not change in cases and controls. Some of the cases had low levels of SHBG than the reference range and level. were decreased significantly when compared with the controls (P = 0.007). Frequently lower levels of SHBG were attributed to the higher frequency of the polymorphism of D327N of the SHBG gene in these men. [14] While further studies have reported androgen receptor gene present on X chromosome as well as mutations in P2RY5 display variable expressivity was a factor underlying both hypotrichosis and alopecia. [15] Although testosterone levels were normal, FAI was significantly higher in cases than controls (P = 0.0006). Free testosterone accelerates gradual transformation large terminal scalp follicles to tiny villous ones causing premature AGA in genetically predisposed person. [16] This shows that FAI is the best marker of a person's androgen status as it can bind to tissue receptors.
Our results are in accordance with studies conducted in the past. [10],[11],[12],[17] PCOS is another common cause of elevated serum DHEA-S levels in women. [18] Though serum DHEA-S is the weak androgen, it functions as a precursor for more potent androgen such as testosterone and dihydrotestosterone (DHT). We found serum levels were normal in both groups. Our finding resembles to previous studies [10],[11],[12],[19] however skin concentration and urinary excretion of DHEA-S was found to be increased in few studies. [20],[21] Hence we support the established fact that premature AGA is not only induced but its chronic course is maintained by the increased local concentration of potent androgens mainly DHT, synthesized from circulating testosterone.
Although androgen profile of men with premature AGA simulate to the hormonal profile of ovarian follicular phase of females, we could not demonstrate changes in pituitary hormones like LH and FSH unlike in previous studies. [18],[22] The present study could not demonstrate insulin resistance in both groups. Insulin resistance was consistently associated with premature AGA in most of the studies conducted in past. [10],[11],[12],[14],[19],[23] This does not correlate with findings of our study as patients were non-obese and were < 30 years of age. Our results could be reinforced by past studies which have correlated insulin resistance with aging [23],[24] and obesity [25] more than AGA.
To summarize we could state that in spite of normal levels of total testosterone in balding men, lower levels SHBG reveals genetic susceptibility for the action of free testosterone in balding men. However it does not fulfill all criterions corresponding to PCOS in females like hyperandrogenism, altered pituitary hormones and increased insulin resistance. Even it couldn't be considered as an expression of metabolic syndrome X due to the absence of insulin resistance which is commonly found in males. [2],[5] Instead same hormonal changes have been observed in females with androgenic alopecia except normal SHBG levels. [26] From the present study, we could conclude that premature AGA might be considered as a separate entity and could not be considered as male PCOS equivalent. Previous studies which found possible equivalence of premature AGA in males to PCOS in females were done in non-Indian population. As our study is limited to Indian population equivalence of premature AGA in men with PCOS in female can't be completely ruled out considering the importance of genetic predisposition. Hence further collaborative studies of larger sample size and with the follow up of hormonal profiles in forties and fifties are needed. We also propose that exact identification of the male PCOS phenotype might be determined by genetic studies.
| References | | |
| 1. | Hoffmann R, Happle R. Current understanding of androgenetic alopecia. Part I: Etiopathogenesis. Eur J Dermatol 2000;10:319-27. 
[PUBMED] |
| 2. | Sinclair RD, Dawber RP. Androgenetic alopecia in men and women. Clin Dermatol 2001;19:167-78.
[PUBMED] |
| 3. | Denmark-Wahnefried W, Schildkraut JM, Thompson D, Lesko SM, McIntyre L, Schwingl P, et al. Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:325-8.
[PUBMED] |
| 4. | Lotufo PA, Chae CU, Ajani UA, Hennekens CH, Manson JE. Male pattern baldness and coronary heart disease: The Physicians' Health Study. Arch Intern Med 2000;160:165-71.
[PUBMED] |
| 5. | Su LH, Chen TH. Association of androgenetic alopecia with metabolic syndrome in men: A community-based survey. Br J Dermatol 2010;163:371-7.
[PUBMED] |
| 6. | Carey AH, Chan KL, Short F, White D, Williamson R, Franks S. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) 1993;38:653-8.
[PUBMED] |
| 7. | Legro RS. Is there a male phenotype in polycystic ovary syndrome families? J Pediatr Endocrinol Metab 2000;13 Suppl 5:1307-9.
[PUBMED] |
| 8. | Govind A, Obhrai MS, Clayton RN. Polycystic ovaries are inherited as an autosomal dominant trait: Analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 1999;84:38-43.
[PUBMED] |
| 9. | Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001;52:401-19.
[PUBMED] |
| 10. | Stárka L, Hill M, Polácek V. Hormonal profile in men with premature androgenic alopecia. Sb Lek 2000;101:17-22.
|
| 11. | Stárka L, Cermáková I, Dusková M, Hill M, Dolezal M, Polácek V. Hormonal profile of men with premature balding. Exp Clin Endocrinol Diabetes 2004;112:24-8.
|
| 12. | Dusková M, Hill M, Stráka L. The polycystic ovary syndrome and its male equivalent. Cas Lek Cesk 2007;146:251-5.
|
| 13. | Norwood OT. Male pattern baldness: Classification and incidence. South Med J 1975;68:1359-65.
[PUBMED] |
| 14. | Vrbikova J, Zavadilova J, Vankova M, Vejrazkova D, Lukasova P, Vcelak J et al. Role of D327N sex-hormone binding globulin gene polymorphism in the pathogenesis of polycystic ovary syndrome. Endocrine Abstracts (2006) 11 P709.
|
| 15. | Shimomura Y, Wajid M, Ishii Y, Shapiro L, Petukhova L, Gordon D, et al. Disruption of P2RY5, an orphan G protein-coupled receptor, underlies autosomal recessive woolly hair. Nat Genet 2008;40:335-9.
[PUBMED] |
| 16. | Rebora A. Pathogenesis of androgenetic alopecia. J Am Acad Dermatol 2004;50:777-9.
[PUBMED] |
| 17. | Schmidt JB, Lindmaier A, Spona J. Hormonal parameters in androgenetic hair loss in the male. Dermatologica 1991;182:214-7.
[PUBMED] |
| 18. | Arlt W, Hammer F, Filko D, Chalder SM, Hughes BA, Sanning P et al. A defect in the DHEA-DHEAS shuttle defines a novel cause of polycystic ovary syndrome. Endocrine Abstracts. 2005;9:OC 11.15.3.
|
| 19. | Tsvetanova A, Gospodinov D, Donchev M. Serum-concentrations of dehydroepyandrosterone- sulfate in men with androgenetic alopecia. Int Med Assoc Bulg 2004;10:38-41.
|
| 20. | Phillipou G, Kirk J. Significance of steroid measurements in male pattern alopecia. Clin Exp Dermatol 1981;6:53-6.
[PUBMED] |
| 21. | Pitts RL. Serum elevation of dehydroepiandrosterone sulfate associated with male pattern baldness in young men. J Am Acad Dermatol 1987;16:571-3.
[PUBMED] |
| 22. | Dusková M, Stárka L. The existence of a male equivalent of the polycystic ovary syndrome - The present state of the issue. Prague Med Rep 2006;107:17-25.
|
| 23. | Nabaie L, Kavand S, Robati RM, Sarrafi-Rad N, Kavand S, Shahgholi L, et al. Androgenic alopecia and insulin resistance: Are they really related? Clin Exp Dermatol 2009;34:694-7.
[PUBMED] |
| 24. | Bloomgarden ZT. Insulin resistance: Current concepts. Clin Ther 1998;20:21-5.
|
| 25. | Abdel Fattah NS, Darwish YW. Androgenetic alopecia and insulin resistance: Are they truly associated? Int J Dermatol 2011;50:417-22.
[PUBMED] |
| 26. | Schmidt JB, Lindmaier A, Trenz A, Schurz B, Spona J. Hormone studies in females with androgenic hairloss. Gynecol Obstet Invest 1991;31:235-9.
[PUBMED] |
[Table 1]
| This article has been cited by | | 1 |
Clinical and metabolic characteristics of males with early-onset androgenetic alopecia |
|
| Vinay Keshavamurthy, Rajsmita Bhattachajee, Anuradha Bishnoi, Akanksha Kaushik, Naresh Sachdeva, Arnab Pal, Tarun Narang, Sunil Dogra | | Indian Journal of Dermatology, Venereology and Leprology. 2022; 0: 1 | | [Pubmed] | [DOI] | | | 2 |
Androgenetic alopecia: What impact does it have on the quality of Life? |
|
| AdemolaOlusegun Enitan, OlayinkaAbimbola Olasode, OlaniyiEmmanuel Onayemi, AtinukeArinola Ajani, OlumayowaAbimbola Oninla, FataiOlatunde Olanrewaju, MufutauMuphy Oripelaye | | Nigerian Journal of Medicine. 2022; 31(4): 455 | | [Pubmed] | [DOI] | | | 3 |
A study on relationship between androgenetic alopecia and cardiovascular risk using high sensitivity C-reactive protein and galectin-3 in men with early onset baldness |
|
| Mehmet Sözen, Süleyman Baldane, Sedat Abusoglu, Levent Kebapcilar, Aysegül Kebapcilar, Fatma Tunçez Akyürek, Ali Ünlü, Süleyman Hilmi Ipekci | | Biomarkers. 2021; : 1 | | [Pubmed] | [DOI] | | | 4 |
Hyperuricemia is associated with androgenetic alopecia in men: A cross-sectional case-control study |
|
| Jingwen Ma, Youyu Sheng, Zhengyin Lao, Jun Zhao, Qinping Yang | | Journal of Cosmetic Dermatology. 2020; 19(11): 3122 | | [Pubmed] | [DOI] | | | 5 |
Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist? |
|
| Rossella Cannarella, Rosita A. Condorelli, Federica Dall’Oglio, Sandro La Vignera, Laura M. Mongioì, Giuseppe Micali, Aldo E. Calogero | | International Journal of Endocrinology. 2020; 2020: 1 | | [Pubmed] | [DOI] | | | 6 |
Glycolipid and Hormonal Profiles in Young Men with Early-Onset Androgenetic Alopecia: A meta-analysis |
|
| Rossella Cannarella, Sandro La Vignera, Rosita A. Condorelli, Aldo E. Calogero | | Scientific Reports. 2017; 7(1) | | [Pubmed] | [DOI] | | | 7 |
The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia |
|
| Anna Skrok, Tomasz Bednarczuk, Agata Skwarek, Michal Popow, Lidia Rudnicka, Malgorzata Olszewska | | Skin Pharmacology and Physiology. 2015; 28(4): 213 | | [Pubmed] | [DOI] | | | 8 |
Androgenic hormone profile in patients with androgenetic alopecia |
|
| I. N. Konrakhina, A. N. Mareeva, P. A. Kalinina, M. G. Abuladze | | Vestnik dermatologii i venerologii. 2015; 91(6): 30 | | [Pubmed] | [DOI] | |
|
 |
|
|
|
